tiprankstipranks
Rohto Pharmaceutical Co Ltd (RPHCF)
OTHER OTC:RPHCF
US Market

Rohto Pharmaceutical Co (RPHCF) Income Statement

Compare
3 Followers

Rohto Pharmaceutical Co Income Statement

Last quarter (Q1 2024), Rohto Pharmaceutical Co's total revenue was ¥68.36B, an increase of 11.75% from the same quarter last year. In Q1, Rohto Pharmaceutical Co's net income was ¥8.48B. See Rohto Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 270.84B¥ 238.66B¥ 199.65B¥ 181.05B¥ 188.38B
Gross Profit
¥ 157.29B¥ 137.42B¥ 116.49B¥ 106.73B¥ 114.24B
Operating Expenses
¥ 117.24B¥ 103.46B¥ 87.14B¥ 83.73B¥ 91.68B
Depreciation and Amortization
¥ 8.69B¥ 7.80B¥ 7.69B¥ 6.75B¥ 6.94B
EBITDA
¥ 50.40B¥ 41.34B¥ 35.81B¥ 28.61B¥ 29.82B
Operating Income
¥ 40.05B¥ 33.96B¥ 29.35B¥ 22.99B¥ 23.09B
Other Income/Expenses
¥ 1.47B¥ 331.00M¥ -1.14B¥ 16.00M¥ -1.35B
Pretax Income
¥ 41.52B¥ 34.29B¥ 27.95B¥ 23.01B¥ 21.73B
Net Income
¥ 30.94B¥ 26.38B¥ 21.13B¥ 16.74B¥ 15.41B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 135.60¥ 115.62¥ 92.61¥ 73.39¥ 67.56
Diluted EPS
¥ 135.21¥ 115.29¥ 92.34¥ 73.18¥ 67.36
Weighted Average Shares Outstanding
228.14M 228.14M 228.14M 228.14M 228.08M
Weighted Average Shares Outstanding (Diluted)
228.80M 228.80M 228.80M 228.80M 228.79M
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis